Abstract:Objective: This systematic review and meta-analysis aimed to investigate the association between circulating irisin levels and osteoporosis in women, exploring irisin's potential role in the pathophysiology and management of osteoporosis. Method: We searched PubMed, Embase, Web of Science, Cochrane Library, CNKI, WanFang, and VIP databases up to January 2023. The inclusion criteria were observational studies reporting on circulating irisin levels in women. The standardized mean difference (SMD) and correlation coefficients with a 95% confidence interval (CI) were used as the main effect measures under a random-effects model. Heterogeneity was evaluated using the Cochrane Q statistic and the I2 statistics. Subgroup analysis and univariate meta-regression analysis were performed to identify the sources of heterogeneity. The quality of the included study was assessed by the Newcastle-Ottawa Score. The quality of evidence was evaluated using the GRADE system. Publication bias was assessed using Begg's and Egger's test, and the trim-and-fill method. Sensitivity analysis was performed to assess the stability of the results. Results: Fifteen studies with a total of 2856 participants met the criteria. The analysis showed significantly lower irisin levels in postmenopausal osteoporotic women compared to non-osteoporotic controls (SMD = -1.66, 95% CI: -2.43 to -0.89, P < 0.0001; I2 = 98%, P < 0.00001) and in postmenopausal individuals with osteoporotic fractures than in non-fractures controls (SMD = -1.25, 95% CI: -2.15 to -0.34, P = 0.007; I2 = 97%, P < 0.00001). Correlation analysis revealed that irisin levels positively correlated with lumbar spine BMD (r = 0.37, 95% CI: 0.18 to 0.54), femoral BMD (r = 0.30, 95% CI: 0.18 to 0.42), and femoral neck BMD (r = 0.31, 95% CI: 0.14 to 0.47) in women. Despite significant heterogeneity, the robustness of the results was supported by using the random effects model and sensitivity analysis. Conclusion: The current evidence suggests that lower irisin levels are significantly associated with osteoporosis and fracture in postmenopausal women, suggesting its utility as a potential biomarker for early detection of osteoporosis and therapeutic target. However, further high-quality prospective research controlling for confounding factors is needed to clarify the relationship between irisin levels and osteoporotic outcomes. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO, identifier CRD42023410264.

Low Serum Concentrations of Irisin Are Associated with Increased Risk of Hip Fracture in Chinese Older Women.

Serum levels of irisin in postmenopausal women with osteoporotic hip fractures

Serum Irisin level is associated with fall risk, muscle strength, and cortical porosity in postmenopausal women

The association between circulating irisin levels and osteoporosis in women: a systematic review and meta-analysis of observational studies

Association of Plasma Irisin with Bone Mineral Density in a Large Chinese Population Using an Extreme Sampling Design

Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients

Serum Levels of Irisin Predict Short-Term Outcomes in Ischemic Stroke.

Association of Irisin and CRP Levels with the Radiographic Severity of Knee Osteoarthritis.

Serum Irisin is Associated with Bone Mineral Density in Postmenopausal T2dm Patients Complicated with Osteoporosis and in Mice with Diabetic Osteoporosis

Estrogen Receptor Α (ESR1) IVS1-397T>C Polymorphism Lowers Risk of Fracture.

Biochemical versus radiological screening for osteoporosis in menopause; will Irisin help?

Irisin Has a Protective Role against Osteoporosis in Ovariectomized Rats

Frailty of the elderly in orthopaedic surgery and body composition changes: the musculoskeletal crosstalk through irisin

Irisin and Its Role in Postmenopausal Osteoporosis and Sarcopenia

Circulating irisin levels in patients with sarcopenia: a systematic review and meta-analysis

Irisin in Elderly People with Hypertension, Diabetes Mellitus Type 2, and Overweight and Obesity

LEVELS OF OSTEOPROTEGERIN AND IRISIN IN POSTMENOPAUSAL OSTEOPOROSIS WOMEN

The Association of Circulating Irisin with Metabolic Risk Factors in Chinese Adults: a Cross-Sectional Community-Based Study

Association between systemic inflammatory response index and bone turnover markers in Chinese patients with osteoporotic fractures: a retrospective cross-sectional study

Association of serum irisin and body composition with chronic kidney disease in obese Chinese adults: a cross-sectional study

Serum Irisin Associates with Breast Cancer to Spinal Metastasis